Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on May 29, 2025
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
GlobeNewswire
·
May 29, 2025
SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will …
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025
GlobeNewswire
·
May 29, 2025
– 14 abstracts accepted, including four oral presentations – – Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice-nightly oxybate to once-at-bedtime LUMRYZ – …
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June: Jefferies 2025 Global Healthcare Conference on Thursday, June 5 …
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) …
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
May 29, 2025
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at the Jefferies Global Healthcare …
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis …
Quit Like Sweden: On its 20th Anniversary, Global Treaty Needs a New Ally
EIN Presswire
·
May 29, 2025
20 years after the landmark FCTC treaty, smoking still kills 8 million yearly. Quit Like Sweden says: it’s time to act, following Sweden's successful model. UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- On the 20th anniversary of the WHO …
In-Depth Analysis Of The Global Continuous Positive Airway Pressure Devices Market: Key Drivers, Trends, Opportunities
EIN Presswire
·
May 29, 2025
The Business Research Company’s Continuous Positive Airway Pressure Devices Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- Are You Aware Of The Strong …
Hyperammonemia Treatment Market to Reach USD 2,450 Million by 2035 Amidst Growing Focus on Rare Disease Therapies | FMI
EIN Presswire
·
May 29, 2025
Hyperammonemia Treatment Market Outlook: Key Trends, Growth Drivers …
Hutchinson-Gilford Progeria Syndrome Market Set for Robust Expansion, Projected to Reach USD 261,956.6 Million by 2035
EIN Presswire
·
May 29, 2025
Emerging therapies and innovations drive Hutchinson-Gilford Progeria Syndrome market growth from 2025 to 2035 across diagnostics and treatment NEWARK, DE, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- The global hutchinson-gilford progeria syndrome …
Global Laband Syndrome Therapeutics Market Set for Strong Growth Amid Advancements in Rare Disease Treatments | FMI
EIN Presswire
·
May 29, 2025
Laband Syndrome Therapeutics Market Set to Evolve with Innovation and Emerging Trends from 2025 to 2035 NEWARK, DE, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- The global laband syndrome therapeutics market is on a significant growth trajectory, …
Theratechnologies Reports on its Annual Meeting of Shareholders
GlobeNewswire
·
May 29, 2025
MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, reported the voting results from its annual meeting of shareholders held today …
Theratechnologies rend compte de son assemblée annuelle des actionnaires
GlobeNewswire
·
May 29, 2025
MONTRÉAL, 29 mai 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, a rapporté les résultats du vote lors de son assemblée annuelle des …
Spectruth DAO and Hippo Protocol Forge Strategic Partnership to Pioneer Epigenetic Research in PTSD
EIN Presswire
·
May 29, 2025
Spectruth DAO’s study uses saliva-based epigenetic testing, AI, and wearables to predict PTSD risk in military/veterans, enabling personalized care. KYIV, KYIV, UKRAINE, May 29, 2025 /EINPresswire.com/ -- Spectruth DAO, a leader in decentralized, …
Global Collateral Ligament Stabilizer System Market To Reach $2.80 Billion By 2029 With A Growth Rate Of 7.1%
EIN Presswire
·
May 29, 2025
The Business Research Company’s Collateral Ligament Stabilizer System Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- The collateral ligament stabilizer …
Time to act on Indigenous health inequities: ending discrimination based on place of residence!
GlobeNewswire
·
May 29, 2025
National Forum on Urban Indigenous Health Governance in Care, Health Services and Healing MONTRÉAL, May 29, 2025 (GLOBE NEWSWIRE) -- During the National Forum on Urban Indigenous Health Governance in Care, Health Services and Healing, the Native Friendship …
Iniquité en santé autochtone : il faut mettre fin à la discrimination basée sur le lieu de résidence.
GlobeNewswire
·
May 29, 2025
Forum national sur la gouvernance urbaine en santé autochtone en matière de soins, de services de santé et de guérison MONTRÉAL, 29 mai 2025 (GLOBE NEWSWIRE) -- À l’occasion du Forum national sur la gouvernance urbaine en santé autochtone en matière de …
Thrombocytopenia Treatment Market to Surpass USD 10,611.9 Million by 2035 Rising Demand for Targeted Therapies | FMI
EIN Presswire
·
May 29, 2025
Explore growth drivers, innovations, and future trends shaping the Thrombocytopenia Treatment Market from 2025 to 2035 NEWARK, DE, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- The global thrombocytopenia treatment market is poised for significant …
Bispecific Antibody Drug Conjugates Clinical Trials Bispecific ADC Market Size Insight
GlobeNewswire
·
May 29, 2025
Delhi, May 29, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals and Future Market Opportunity Outlook 2029 Report: Report Answers Question On Why There Exist Need For Bispecific Antibody Drug …